Ginkgo
Ginkgo biloba 50:1 extract
- Products
- 3
NIH LiverTox — hepatotoxicity
Category D · Possible cause
LiverTox Category D (hepatotoxicity — separate concern from IARC Group 2B carcinogenicity classification). A handful of hepatitis reports.
LiverTox record (NIH NCBI Bookshelf) →Label dose distribution · 3 labeled products
Min
120 mg
Typical
160 mg
Max
240 mg
Other forms of Ginkgo
25 sibling forms
Distinct chemical forms sharing the same parent nutrient. Different UNIIs, different bioavailability, different effects — never collapsed.
- 1,018Ginkgo bilobaUNIIherb
- 528Ginkgo biloba extractherb
- 369Ginkgo biloba Leaf ExtractUNIIherb
- 323Ginkgo Leaf ExtractUNIIherb
- 153Ginkgo Extractherb
- 78GinkgoUNIIherb
- 50Ginkgo (Ginkgo biloba) leaf extractUNIIherb
- 46Ginkgo biloba Powderherb
- 32Ginkgo (leaves) extractUNIIherb
- 32Ginkgo powderherb
- 20Ginkgo leaf powderherb
- 20Ginkgo biloba std. ext.herb
- 19Ginkgold Ginkgo biloba extractherb
- 18Ginkgo (Ginkgo biloba) extractUNIIherb
- 17Standardized Ginkgo Biloba Extractherb
- 17Ginkgo biloba standardized extractherb
- 16Gingko biloba extractUNIIherb
- 16Ginkgo leaf ext.herb
- 13Ginkgo biloba leaf powderherb
- 12Ginkgo biloba Leaves ExtractUNIIherb
- 11Ginkgo biloba 50:1 leaf extractUNIIherb
- 11Ginkgo biloba leaf extract powderherb
- 10Gingko Extractherb
- 10Ginkgo (Ginkgo biloba) leaf std. extractherb
- 9Gingko leaf extractherb
Products with avoid-level excipients
1
contain Ginkgo biloba 50:1 extract AND at least one authority-avoid-flagged excipient
Products with caution-level excipients
2
contain Ginkgo biloba 50:1 extract alongside a caution-flagged filler
Top brands carrying Ginkgo biloba 50:1 extract
15 brands rolled up
Products containing Ginkgo biloba 50:1 extract